Lung cancer in women.

Recent biological advances in tumor research provide clear evidence that lung cancer in females is different from that in males. These differences appear to have a direct impact on the clinical presentation, histology, and outcomes of lung cancer. Women are more likely to present with lung adenocarcinoma, tend to receive a diagnosis at an earlier age, and are more likely to be diagnosed with localized disease. Women may also be more predisposed to molecular aberrations resulting from the carcinogenic effects of tobacco, but do not appear to be more susceptible than men to developing lung cancer. The gender differences found in female lung cancer make it mandatory that gender stratification is used in clinical trials in order to improve the survival rates of patients with lung cancer.

• Publication year

  2012

• Venue

  Lung Cancer

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/LCTT.S37319PMID 28210127PMCID PMC5312492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients.

  2012cited by this paper
• Association between the ERCC5 Asp1104His Polymorphism and Cancer Risk: A Meta-Analysis

  2012cited by this paper
• Lung cancer in never smokers--a review.

  2012cited by this paper
• Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.

  2012cited by this paper
• Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence

  2012cited by this paper
• K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value

  2012cited by this paper
• Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains

  2012cited by this paper
• Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.

  2011cited by this paper
• Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

  2011cited by this paper
• Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells.

  2011cited by this paper
• Aromatase in human lung carcinoma.

  2011cited by this paper
• Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.

  2011cited by this paper
• New targets in advanced NSCLC: EML4-ALK.

  2011cited by this paper
• ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer

  2011cited by this paper
• Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.

  2011cited by this paper
• CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review

  2011cited by this paper
• Reproductive and Hormonal Factors and Lung Cancer Risk in the NIH-AARP Diet and Health Study Cohort

  2011cited by this paper
• Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation

  2010cited by this paper
• Lung Cancer Risk and Genetic Polymorphisms in DNA Repair Pathways: A Meta-Analysis

  2010cited by this paper
• ERCC1, RRM1, and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.

  2010cited by this paper
• The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials.

  2010cited by this paper
• Phase II trial evaluating addition of fulvestrant to erlotinib in patients with stage IIIb/IV non-small cell lung cancer (NSCLC) who are stable on erlotinib and exhibit immunohistochemical (IHC) or PCR positivity for estrogen or progesterone receptor (PR).

  2010cited by this paper
• ERCC2/XPD Lys751Gln and Asp312Asn Gene Polymorphism and Lung Cancer Risk: A Meta-Analysis Involving 22 Case–Control Studies

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Hormone Therapy and Risk of Lung Cancer: A Meta-Analysis

  2010cited by this paper
• Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.

  2010cited by this paper
• Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis.

  2010cited by this paper
• RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

  2010cited by this paper
• Combined Analysis of Estrogen Receptor β-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome

  2010cited by this paper
• Genetic basis for susceptibility to lung cancer: Recent progress and future directions.

  2010cited by this paper
• Differential expression of biomarkers in men and women.

  2009cited by this paper
• Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.

  2009cited by this paper
• Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.

  2009cited by this paper
• Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma

  2009cited by this paper
• KRAS mutations in non-small cell lung cancer.

  2009cited by this paper
• Genetic susceptibility of lung cancer associated with common variants in the 3′ untranslated regions of the adenosine triphosphate‐binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export

  2009cited by this paper
• Lung Cancer in Asian Women

  2009cited by this paper
• Different impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabine.

  2009cited by this paper
• Lung cancer.

  2008cited by this paper
• The use of first-generation tyrosine kinase inhibitors in patients with NSCLC and somatic EGFR mutations.

  2008cited by this paper
• Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

  2008cited by this paper
• Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study.

  2008cited by this paper
• EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future.

  2008cited by this paper
• Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma

  2008cited by this paper
• Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort

  2008cited by this paper
• Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India

  2008cited by this paper
• Reproductive and hormonal factors and risk of lung cancer in women: A prospective cohort study

  2007cited by this paper
• Human CYP2A6 Is Induced by Estrogen via Estrogen Receptor

  2007cited by this paper
• Lung cancer incidence in never smokers.

  2007cited by this paper
• Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Lung cancer, smoke exposure, and sex.

  2007cited by this paper
• Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials

  2007cited by this paper
• Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile

  2007cited by this paper
• Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis

  2007cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• Lung cancer in never smokers — a different disease

  2007cited by this paper
• Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.

  2007cited by this paper
• Lung cancer in never smokers: a review.

  2007cited by this paper
• Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.

  2007cited by this paper
• Risk factors differ for non‐small‐cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case‐control study in Japanese

  2007cited by this paper
• Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.

  2007influential reference
• Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.

  2007influential reference
• Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.

  2006influential reference
• Hormone replacement therapy is associated with decreased survival in women with lung cancer.

  2006cited by this paper
• Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006influential reference
• Female sex and oral contraceptive use accelerate nicotine metabolism

  2006cited by this paper
• Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.

  2006influential reference
• Somatic mutations of the ERBB4 kinase domain in human cancers

  2006cited by this paper
• Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

  2006cited by this paper
• Survival Differences by Sex for Patients with Advanced Non-small Cell Lung Cancer on Eastern Cooperative Oncology Group Trial 1594

  2006cited by this paper
• [Association of genetic polymorphism in the DNA repair gene XPD with risk of lung cancer in nonsmoking females].

  2006cited by this paper
• Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

  2006cited by this paper
• Determinants of the rate of nicotine metabolism and effects on smoking behavior

  2006cited by this paper
• [Epidemiology of tobacco use in Mexico].

  2006cited by this paper
• Worldwide trends in lung cancer pathology

  2006cited by this paper
• Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.

  2006cited by this paper
• Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer.

  2006cited by this paper
• Epidemiología del tabaquismo en México

  2006cited by this paper
• Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

  2005cited by this paper
• Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer

  2005cited by this paper
• Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.

  2005cited by this paper
• Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.

  2005cited by this paper
• Indoor air pollution as a risk factor for lung cancer in women.

  2005cited by this paper
• Contemporary Lung Cancer Trends among U.S. Women

  2005cited by this paper
• Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database.

  2005cited by this paper
• Metabolism and Disposition Kinetics of Nicotine

  2005cited by this paper
• Novel strategies for the early detection and prevention of lung cancer.

  2005cited by this paper
• Nuclear Estrogen Receptor β in Lung Cancer: Expression and Survival Differences by Sex

  2005cited by this paper
• EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.

  2005cited by this paper
• Lung cancer and indoor pollution from heating and cooking with solid fuels: the IARC international multicentre case-control study in Eastern/Central Europe and the United Kingdom.

  2005cited by this paper
• Cytochrome P450-mediated metabolism of estrogens and its regulation in human.

  2005cited by this paper
• Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

  2004cited by this paper
• Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.

  2004cited by this paper
• The role of EGFR inhibitors in nonsmall cell lung cancer

  2004cited by this paper
• Lung adenocarcinoma and human papillomavirus infection

  2004cited by this paper
• Tobacco smoking and cancer: a brief review of recent epidemiological evidence.

  2004cited by this paper
• Lung cancer rates in men and women with comparable histories of smoking.

  2004cited by this paper
• Gender differences in lung cancer: have we really come a long way, baby?

  2004cited by this paper
• The TP53 gene, tobacco exposure, and lung cancer

  2003cited by this paper

• Sex Disparity in Cancer: Role of Autophagy and Estrogen Receptors

  2025cites this paper
• Non-small Cell Lung Cancer in Women: Experience From the National Institute of Oncology, Rabat, Morocco

  2025cites this paper
• Perioperative Outcomes of Lung Cancer Surgery in Women: A Canadian Nationwide Retrospective Cohort Study

  2025cites this paper
• Incidence, prevalence, and survival of lung cancer in the United Kingdom from 2000–2021: a population-based cohort study

  2024cites this paper
• Hsa_circ_0008133 contributes to lung cancer progression by promoting glycolysis metabolism through the miR‐760/MEX3A axis

  2024cites this paper
• Lung cancer statistics, 2023

  2024cites this paper
• The global, regional, and national disease burden of breast cancer attributable to tobacco from 1990 to 2019: a global burden of disease study

  2024cites this paper
• Evolution of Diagnoses, Survival, and Costs of Oncological Medical Treatment for Non-Small-Cell Lung Cancer over 20 Years in Osona, Catalonia

  2024cites this paper
• The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.

  2023cites this paper
• Sex Differences in Sphingosine-1-Phosphate Levels Are Dependent on Ceramide Synthase 1 and Ceramidase in Lung Physiology and Tumor Conditions

  2023cites this paper
• X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma

  2023cites this paper
• Lung cancer in middle and southern Morocco

  2023cites this paper
• Profile of Lung Cancer in two Niger Delta States of Nigeria: An Evaluation of 43 Cases

  2023cites this paper
• Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities

  2023cites this paper
• Health inequities across the lung cancer care continuum in ten marginalized populations: a narrative review

  2023cites this paper
• Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications

  2023cites this paper
• Microvascular Aging and Eicosanoids-Women's Evaluation of Systemic Aging Tenacity (“You are never too old to become younger!”) Specialized Center of Research Excellence on Sex Differences Career Enhancement Core: Building the Future

  2023cites this paper
• Machine-Learning-Aided Prediction of Brain Metastases Development in Non-Small-Cell Lung Cancers.

  2023cites this paper
• Gender disparities in lung cancer incidence in the United States during 2001–2019

  2023cites this paper
• In Vitro Cell Death Mechanisms Induced by Dicoma anomala Root Extract in Combination with ZnPcS4 Mediated-Photodynamic Therapy in A549 Lung Cancer Cells

  2022cites this paper
• The evolving landscape of sex-based differences in lung cancer: a distinct disease in women

  2022cites this paper
• Clinical and genetic characteristics of early‐stage multiple primary and independent primary lung adenocarcinoma patients

  2022cites this paper
• Optimal Lung Cancer Screening Criteria Among Persons Living With HIV

  2022cites this paper
• Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry

  2022cites this paper
• Risk Factors for Lung Cancer in the Province of Lecce: Results from the PROTOS Case–Control Study in Salento (Southern Italy)

  2022cites this paper
• Effects of Tobacco Smoking on the Survivability of Patients with Multiple Cancers and Single Lung Cancer

  2022cites this paper
• First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective

  2021cites this paper
• Texture features of primary tumor on 18F-FDG PET images in non-small cell lung cancer: The relationship between imaging and histopathological parameters.

  2021cites this paper
• Dual Nature of Relationship between Mycobacteria and Cancer

  2021cites this paper
• Role of sex hormones in lung cancer

  2021cites this paper
• An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment

  2021cites this paper
• Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review

  2021cites this paper
• Cancer-related mortality in Peru: Trends from 2003 to 2016

  2020cites this paper
• Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries

  2020cites this paper
• The molecular basis of gender disparities in smoking lung cancer patients.

  2020cites this paper
• Texture features of primary tumor on 18F-FDG PET images in non-small cell lung cancer: The relationship between imaging and histopathological parameters.

  2020cites this paper
• Understanding sex disparities in lung cancer incidence: are women more at risk?

  2020cites this paper
• Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression

  2020cites this paper
• Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.

  2020cites this paper
• The Role of Sublobar Resection in T1 N0 Non-Small-Cell Pulmonary Carcinoma.

  2020cites this paper
• Longitudinal relationships between lung cancer mortality rates, smoking, and ambient air quality: a comprehensive review and analysis

  2019cites this paper
• Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.

  2019cites this paper
• A qualitative study of healthcare-related experiences of non-smoking women with lung cancer

  2019cites this paper
• “Age matters”—German claims data indicate disparities in lung cancer care between elderly and young patients

  2019cites this paper
• Perioperative outcome of lung cancer surgery in women: results from a Spanish nationwide prospective cohort study.

  2019cites this paper
• Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling

  2019cites this paper
• Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?

  2019cites this paper
• Higher Lung Cancer Incidence in Young Women Than Young Men in the United States

  2018cites this paper
• Number of radiotherapy treatment machines in the population and cancer mortality: an ecological study

  2018cites this paper
• Controllability of Network: Identification of Controller Genes in a Gene–Gene Interaction Network

  2018cites this paper
• Lung cancer in women: a single institution experience with 50 patients.

  2014cites this paper
• CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review

  2011cites this paper